Table 1.
% (N = 100) | |
---|---|
Age (years) | |
Median | 53.5 |
Range | 18–83 |
Gender | |
Female | 59 |
Male | 41 |
Primary cancer | |
Breast | 40 |
Prostate | 15 |
Kaposi Sarcoma | 10 |
Lung | 8 |
Othera | 27 |
ECOG-PS | |
0–1 | 64 |
2 | 7 |
3–4 | 4 |
Unknown | 25 |
Stage of disease | |
I | 1 |
II | 6 |
III | 20 |
IV | 61 |
Unstagedb | 12 |
Treatment | |
Chemotherapy | 97 |
Radiotherapy | 7 |
Surgery | 1 |
Patient status | |
Existing | 79 |
New | 21 |
Number of chemotherapy cycles received (N = 73) | |
Mean ± SD | 4.71 ± 2.88 |
Range | 1–14 |
aOther cancers include colon, esophagus, pancreas, rectum
b Includes Kaposi sarcoma patients, where there is no officially accepted system for staging (n = 10), and new patients that did not have their disease staged yet (n = 2)